Navigation Links
ClinicalRM to Co-Present Regulatory Compliance Panel at MAGI
Date:10/26/2011

LAS VEGAS, Oct. 26, 2011 /PRNewswire/ -- Clinical Research Management, (ClinicalRM) a full-service Contract Research Organization providing services for basic and applied research, clinical trials, and regulatory support, announced today its Senior Scientific Director, Dr. Jere M. Boyer, Ph.D., will co-present a panel titled Battle of Compliance: FDA vs. OHRP vs. ICH at the MAGI West Clinical Research Conference, October 23-26, 2011 in Las Vegas, NV.  The panel will discuss the important differences in clinical research regulations, guidelines and guidances between the United States Food and Drug Administration (FDA), the United States Department of Health and Human Resources Office for Human Research Protections (OHRP), and the International Conference on Harmonization (ICH).  MAGI is the Model Agreements and Guidelines International organization whose mission is to standardize best practices for clinical research operations, business, and regulatory compliance.

Dr. Boyer, a Certified IRB Manager (CIM), Certified IRB Professional (CIP), Certified Clinical Research Professional (CCRP), and a Clinical Laboratory Director/Diplomat in Clinical Microbiology for the American Board of Bioanalysis, is an established speaker and author, with specific focus on the growing complexity of managing Human Subject Protection over the past decade.

"The MAGI conference presents a great forum for sharing our collective expertise in compliance across regulatory groups that affect clinical research management," said Victoria Tifft, founder and CEO of ClinicalRM.  Said Tifft, "Dr. Boyer is an expert on the topic of Human Subject Protection and will offer valuable insight into the accountability and execution of these types of requirements in the clinical setting."

About ClinicalRM

Founded in 1992, ClinicalRM is a full service Contract Research Organization (CRO) specializing in preclinical, and Phase I to Phase IV clinical research, clinical trial support, and product development for biologics, drugs, and devices. ClinicalRM pride's itself on providing outstanding customer service and exceeding client expectations. For more information, please go to: www.clinicalrm.com

Contact:
Dana Stanton
dstanton@clinicalrm.com
Ph: 800-431-9640   Fax: 800-538-1420
For General Information: info@clinicalrm.com


'/>"/>
SOURCE Clinical Research Management (ClinicalRM)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Clinical Research Management, a Full-Service CRO, Changes Its Name to ClinicalRM
2. FDA Invests $2 Million in Partnerships Through Centers of Excellence in Regulatory Science and Innovation
3. Delcath Announces Completion of Regulatory Notification Process in New Zealand
4. Boston Scientific Welcomes Introduction of Medical Device Regulatory Improvement Act in U.S. Senate
5. Insmed Incorporated Provides Regulatory Update on ARIKACEĀ® in Non-Tuberculous Mycobacteria Indication
6. Insmed Incorporated Provides Regulatory Update
7. EMDT Launches New Specialist Conference on Managing Regulatory Change for Medical Devices
8. Genesis Biopharma Adds Cell Therapy Bioprocess Engineering, Clinical Trial Design, Biostatistics, Regulatory Affairs and FDA Compliance Expertise
9. VIVUS Provides Regulatory Update on QNEXA
10. Novo Nordisk Inc. Appoints Eddie Li as Vice President, Regulatory Affairs
11. Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2017)... June 7, 2017 Endo International plc (NASDAQ: ... 2017, the Hon. Joseph R. Goodwin , U.S. ... West Virginia , entered a case management ... Repair System Products Liability Litigation (the "MDL") that includes ... to provide expert disclosures on specific causation within one ...
(Date:6/3/2017)... 3, 2017  Eli Lilly and Company (NYSE: ... from the Phase 3 MONARCH 2 study showed ... inhibitor, in combination with fulvestrant, significantly improved progression-free ... in women with hormone-receptor-positive (HR+), human epidermal growth ... have relapsed or progressed after endocrine therapy (median ...
(Date:5/30/2017)... May 30, 2017 Therapix Biosciences Ltd. (Nasdaq: ... in the development of cannabinoid-based drugs, today announced ... overview at three upcoming scientific and investor conferences ... Micro Invitational: ... Date:                     Wednesday, ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... "The Better Care Reconciliation Act ... harm to people with all chronic conditions, including mental illnesses, while increasing the ... the Affordable Care Act (ACA) requirement that insurers cover pre-existing conditions, it does ...
(Date:6/23/2017)... ... ... Studies show evidence that carotenoids and antioxidants derived either from the diet or from ... how often do ophthalmologists and optometrists in Sweden recommend the use of nutritional supplements, ... symptoms of AMD? A study published recently in Dove Medical Press journal, ...
(Date:6/23/2017)... ... June 23, 2017 , ... Military Connection friend and veteran ... the JFK Virgin Atlantic lounge. , Bensko is no stranger to the plight ... Bensko dedicated her life to supporting our wounded veterans. A world-class photographer, her riveting ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Aesthetic Channel has recently highlighted ... has come up with a proprietary technique that he calls the AuraLyft ... dropped. For all ages, patients can expect to look refreshed, rejuvenated, and revitalized. ...
(Date:6/23/2017)... ... ... 21 Middle East and South Asia Leaders Selected as Eisenhower Fellows , ... society in 11 countries across the Middle East and South Asia to embark on ... knowledge and ideas with the leading minds in their fields. , For the ...
Breaking Medicine News(10 mins):